TLR2 and chronic obstructive pulmonary disease: The effects of FP on receptor expression were limited to restoration of SP-mediated receptor reductions of TLR2 and TLR4, and increasing CD16 above baseline; though effects were observed in both COPD-ES and COPD-S (TLR2 and CD16).